Patents by Inventor Benjamin Greenman

Benjamin Greenman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5525472
    Abstract: Applicants describe methods for purifying human ApoE or analog thereof from recombinant bacterial cells with minimal protein aggregation and degradation during the purification process. The invention involves the addition of neutralized fatty acids to the medium during cell disruption and the use of a non-ionic detergent during the purification process. Additionally applicants describe a method for increasing the production of ApoE or analog thereof in a bacterial host by adding to the culture medium neutralized fatty acids, fatty acid precursors, triglycerides, triglyceride precursors or acetate. Pharmaceutical and diagnostic uses of the ApoE analog are described.
    Type: Grant
    Filed: November 3, 1994
    Date of Patent: June 11, 1996
    Assignee: Bio-Technology General Corp.
    Inventors: Ruth Lifshitz, Meir Fischer, Benjamin Greenman, Daniel Bartfeld
  • Patent number: 4784991
    Abstract: Heavy metal salts of hyaluronic acid have been prepared. In particular, this invention is directed to silver, gold, cerium and tungsten salts of hyaluronic acid. These heavy metal salts of hyaluronic acid are useful as antimicrobial agents. Gold hyaluronate may also be used to treat arthritis.This invention also concerns methods of making the silver salt of hyaluronic acid as well as compositions containing silver hyaluronate or gold hyaluronate.The invention also concerns composition containing heavy metal salts having radioactively labelled hyaluronate moieties.
    Type: Grant
    Filed: March 9, 1987
    Date of Patent: November 15, 1988
    Assignee: Bio-Technology General Corp.
    Inventors: Abraham Nimrod, Benjamin Greenman
  • Patent number: 4784990
    Abstract: A novel mutant microorganism Streptococcus zooepidemicus HA-116 ATCC 39920, has been produced. The microorganism produces large amounts of high molecular weight hyaluronic acid. The invention provides a method of obtaining such microorganisms.The invention also concerns a method of obtaining sodium hyaluronate which comprises growing with vigorous agitation a microorganism of the genus Streptococcus under appropriate conditions in a suitable nutrient medium containing a sugar component as a carbon source. The sugar component is present in a substantially constant concentration between 0.2 and 10 grams per liter. The medium has a substantially constant pH between about 6.0 and 7.5 and includes a substantially constant magnesium ion concentration above 0.05 grams per liter. The sodium hyaluronate excreted into the medium by the organism is purified using methods involving precipitation, redissolving and reprecipitating the hyaluronate.
    Type: Grant
    Filed: January 18, 1985
    Date of Patent: November 15, 1988
    Assignee: Bio-Technology General Corporation
    Inventors: Abraham Nimrod, Benjamin Greenman, Dov Kanner, Moshe Landsberg
  • Patent number: 4780414
    Abstract: A novel mutant microorganism Streptococcus zooepidemicus HA-116 ATCC 39920, has been produced. The microorganism produces large amounts of high molecular weight hyaluronic acid. The invention provides a method of obtaining such microorganisms.The invention also concerns a method of obtaining sodium hyaluronate which comprises growing with vigorous agitation a microorganism of the genus Streptococcus under appropriate conditions in a suitable nutrient medium containing a sugar component as a carbon source. The sugar component is present in a substantially constant concentration between 0.2 and 10 grams per liter. The medium has a substantially constant pH between about 6.0 and 7.5 and includes a substantially constant magnesium ion concentration above 0.05 grams per liter. The sodium hyaluronate excreted into the medium by the organism is purified using methods involving precipation, redissolving and reprecipating the hyaluronate.
    Type: Grant
    Filed: January 9, 1986
    Date of Patent: October 25, 1988
    Assignee: Bio-Technology General Corp.
    Inventors: Abraham Nimrod, Benjamin Greenman, Dov Kanner, Moshe Landsberg, Yaffa Beck
  • Patent number: 4746504
    Abstract: Heavy metal salts of hyaluronic acid have been prepared. In particular, this invention is directed to silver, gold, cerium and tungsten salts of hyaluronic acid. These heavy metal salts of hyaluronic acid are useful as antimicrobial agents. Gold hyaluronate may also be used to treat arthritis. This invention also concerns methods of making the silver salt of hyaluronic acid as well as compositions containing silver hyaluronate or gold hyaluronate. The invention also concerns composition containing heavy metal salts having radioactively labelled hyaluronate moieties.
    Type: Grant
    Filed: March 14, 1986
    Date of Patent: May 24, 1988
    Assignee: Bio-Technology General Corp.
    Inventors: Abraham Nimrod, Benjamin Greenman